In the first comparative clinical trial of lung cancer screening decision aid versus standard educational information, researchers from MD Anderson Cancer Center demonstrated that a decision aid delivered through tobacco quitlines effectively reaches a screening-eligible population and results in informed decisions about lung cancer screening.
An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.
